INBRAIN Neuroelectronics Completes Enrollment of World's First-in-Human Study of Graphene Neural Interfaces
Summary
INBRAIN Neuroelectronics announced completion of patient enrollment for the world's first-in-human study evaluating graphene-based neural interfaces for brain decoding and mapping. The study assesses the safety and performance of INBRAIN's graphene electrodes in patients undergoing brain surgery. The company's technology leverages the unique properties of graphene to create high-resolution, biocompatible neural interfaces.
Why it matters
This milestone represents a significant step forward for graphene-based brain-computer interface technology, which could offer superior electrical properties and biocompatibility compared to traditional metal electrodes. Graphene's high conductivity and flexibility make it an attractive material for long-term neural recording and stimulation. Successful completion of this first-in-human study could validate graphene as a next-generation material for neural interfaces and open new possibilities for BCI therapeutics.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial